TIL Desk/Business/New Delhi/ Joining the long list of firms to launch its own brand of oral antiviral drug favipiravir, the country’s largest drugmaker Sun Pharmaceutical Industries on Tuesday launched the cheapest brand of favipiravir in the market – FluGuard. Priced at Rs 35 a tablet this will be the cheapest brand available so far.
Jenburkt Pharma’s brand Favivent is priced at Rs 39 per tablet. Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.
Kirti Ganorkar, CEO of India Business, Sun Pharma said, “With over 50,000 Covid-19 cases being reported daily in India, there is an urgent need to provide more treatment options to healthcare professionals.
“We are launching FluGuard at an economical price to make the drug accessible to more and more patients thereby reducing their financial burden.”
